These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 18815192)

  • 1. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease].
    Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Hao L; Wang YZ; Jiang B; Lu XJ; Liu YR; Huang XJ; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):441-5. PubMed ID: 19035174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.
    Qin Y; Zhu H; Jiang B; Li J; Lu X; Li L; Ruan G; Liu Y; Chen S; Huang X
    Leuk Res; 2009 Mar; 33(3):384-90. PubMed ID: 18950857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantification of the PRAME transcripts in patients with acute myeloid leukemia].
    Zhu ZH; Qian J; Lin J; Yao DM; Qian Z; Wang YL; Chen Q; Han LX; Xiao G
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):149-52. PubMed ID: 20376794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognostic and predictive relevance of PRAME in breast cancer.
    Doolan P; Clynes M; Kennedy S; Mehta JP; Crown J; O'Driscoll L
    Breast Cancer Res Treat; 2008 May; 109(2):359-65. PubMed ID: 17624586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia.
    Spanaki A; Perdikogianni C; Linardakis E; Kalmanti M
    Leuk Res; 2007 May; 31(5):639-42. PubMed ID: 16860864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
    Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
    Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD2+ acute promyelocytic leukemia is associated with leukocytosis, variant morphology and poorer prognosis.
    Kaito K; Katayama T; Masuoka H; Nishiwaki K; Sano K; Sekiguchi N; Hagino T; Kobayashi M
    Clin Lab Haematol; 2005 Oct; 27(5):307-11. PubMed ID: 16178910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hTERT mRNA levels by real-time RT-PCR in acute myelogenous leukemia.
    Huh HJ; Huh JW; Yoo ES; Seong CM; Lee M; Hong KS; Chung WS
    Am J Hematol; 2005 Aug; 79(4):267-73. PubMed ID: 16044449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia.
    Lee JJ; Cho D; Chung IJ; Cho SH; Park KS; Park MR; Ryang DW; Kim HJ
    Am J Hematol; 2003 Jul; 73(3):149-53. PubMed ID: 12827650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
    Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
    Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
    Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
    Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
    Ortmann CA; Eisele L; Nückel H; Klein-Hitpass L; Führer A; Dührsen U; Zeschnigk M
    Ann Hematol; 2008 Oct; 87(10):809-18. PubMed ID: 18587578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome.
    Oberthuer A; Hero B; Spitz R; Berthold F; Fischer M
    Clin Cancer Res; 2004 Jul; 10(13):4307-13. PubMed ID: 15240516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.